Work

A Study to Evaluate Relative Bioavailability, Food Effect, and Pharmacodynamics of Tropifexor, a Farnesoid X Receptor Agonist, in Healthy Participants

Year: 2022

Type: article

Study design: Clinical Trial

Source: Clinical Pharmacology in Drug Development

DOI: 10.1002/cpdd.1208

Authors: Rowan Stringer, Jin Chen, Bharti Shah, Jessie Gu, Yiming Zhang, William Prince, Lloyd B. Klickstein, Ralph Woessner

Institutions: Novartis (Switzerland), Novartis Institutes for BioMedical Research, Novartis (United States)

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4311027674

FWCI:

Cites: 26

Cited by:

Related to: 10